These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25339844)

  • 1. LONGER-TERM EFFECTIVENESS OF CBT IN TREATMENT OF COMORBID AUD/MDD ADOLESCENTS.
    Cornelius JR; Douaihy AB; Kirisci L; Daley DC
    Int J Med Biol Front; 2013; 19(2):. PubMed ID: 25339844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cognitive behavioral therapy/motivational enhancement therapy (CBT/MET) in a treatment trial of comorbid MDD/AUD adolescents.
    Cornelius JR; Douaihy A; Bukstein OG; Daley DC; Wood SD; Kelly TM; Salloum IM
    Addict Behav; 2011 Aug; 36(8):843-8. PubMed ID: 21530092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TREATMENT TRIAL AND LONG-TERM FOLLOW-UP EVALUATION AMONG COMORBID YOUTH WITH MAJOR DEPRESSION AND A CANNABIS USE DISORDER.
    Cornelius JR; Salloum IM; Ferrell R; Douaihy AB; Hayes J; Kirisci L; Horner M; Daley DC
    Int J Med Biol Front; 2012; 18(6):399-411. PubMed ID: 25328373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder.
    Cornelius JR; Bukstein OG; Wood DS; Kirisci L; Douaihy A; Clark DB
    Addict Behav; 2009 Oct; 34(10):905-9. PubMed ID: 19321268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onset of alcohol or substance use disorders following treatment for adolescent depression.
    Curry J; Silva S; Rohde P; Ginsburg G; Kennard B; Kratochvil C; Simons A; Kirchner J; May D; Mayes T; Feeny N; Albano AM; Lavanier S; Reinecke M; Jacobs R; Becker-Weidman E; Weller E; Emslie G; Walkup J; Kastelic E; Burns B; Wells K; March J
    J Consult Clin Psychol; 2012 Apr; 80(2):299-312. PubMed ID: 22250853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults.
    Cornelius JR; Bukstein OG; Douaihy AB; Clark DB; Chung TA; Daley DC; Wood DS; Brown SJ
    Drug Alcohol Depend; 2010 Nov; 112(1-2):39-45. PubMed ID: 20576364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine in depressed AUD adolescents: a 1-year follow-up evaluation.
    Cornelius JR; Bukstein OG; Salloum IM; Kelly TM; Wood DS; Clark DB
    J Child Adolesc Psychopharmacol; 2004; 14(1):33-8. PubMed ID: 15142389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating Comorbid Social Anxiety and Alcohol Use Disorders: Combining Motivation Enhancement Therapy With Cognitive-Behavioral Therapy.
    Buckner JD; Ledley DR; Heimberg RG; Schmidt NB
    Clin Case Stud; 2008 Jun; 7(3):208-223. PubMed ID: 20414473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine in adolescents with comorbid major depression and an alcohol use disorder: a 3-year follow-up study.
    Cornelius JR; Clark DB; Bukstein OG; Kelly TM; Salloum IM; Wood DS
    Addict Behav; 2005 May; 30(4):807-14. PubMed ID: 15833583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mirtazapine in Comorbid Major Depression and Alcohol Use Disorder: A Long-Term Follow-Up Study.
    Cornelius JR; Douaihy AB; Clark DB; Daley DC; Chung TA; Wesesky MA; Wood DS; Salloum I
    J Addict Behav Ther Rehabil; 2013 Aug; 3(1):. PubMed ID: 25374892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine in adolescents with major depression and an alcohol use disorder: an open-label trial.
    Cornelius JR; Bukstein OG; Birmaher B; Salloum IM; Lynch K; Pollock NK; Gershon S; Clark D
    Addict Behav; 2001; 26(5):735-9. PubMed ID: 11676382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy, acceptability, and safety of medicinal, cognitive-behavioral therapy, and placebo treatments for acute major depressive disorder in children and adolescents: a multiple-treatments meta-analysis.
    Ma D; Zhang Z; Zhang X; Li L
    Curr Med Res Opin; 2014 Jun; 30(6):971-95. PubMed ID: 24188102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of comorbid major depressive disorder or bipolar disorder on cognitive behavioral therapy for social anxiety disorder.
    Fracalanza K; McCabe RE; Taylor VH; Antony MM
    J Affect Disord; 2014 Jun; 162():61-6. PubMed ID: 24767007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbid alcohol use disorder in psychiatric MDD patients: A five-year prospective study.
    Holma M; Holma I; Isometsä E
    J Affect Disord; 2020 Apr; 267():283-288. PubMed ID: 32217228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review of the Literature of Mirtazapine in Co-Occurring Depression and an Alcohol Use Disorder.
    Cornelius JR; Chung TA; Douaihy AB; Kirisci L; Glance J; Kmiec J; Wesesky MA; FitzGerald D; Salloum I
    J Addict Behav Ther Rehabil; 2016; 5(4):. PubMed ID: 28393081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continued Effectiveness of Relapse Prevention Cognitive-Behavioral Therapy Following Fluoxetine Treatment in Youth With Major Depressive Disorder.
    Emslie GJ; Kennard BD; Mayes TL; Nakonezny PA; Moore J; Jones JM; Foxwell AA; King J
    J Am Acad Child Adolesc Psychiatry; 2015 Dec; 54(12):991-8. PubMed ID: 26598474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Patient-reported Outcomes of Quality of Life and Functioning Before and After Treatment of Major Depressive Disorder Comorbid With Alcohol Use Disorders.
    Danovitch I; Steiner AJ; Kazdan A; Goldenberg M; Haglund M; Mirocha J; Collison K; Vanle B; Dang J; IsHak WW
    J Addict Med; 2017; 11(1):47-54. PubMed ID: 27763941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressed patients with co-occurring alcohol use disorders: a unique patient population.
    Sher L; Stanley BH; Harkavy-Friedman JM; Carballo JJ; Arendt M; Brent DA; Sperling D; Lizardi D; Mann JJ; Oquendo MA
    J Clin Psychiatry; 2008 Jun; 69(6):907-15. PubMed ID: 18422397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic efficacy of fluoxetine, escitalopram, sertraline, paroxetine, and concomitant psychotherapy in major depressive disorder: outcome after long-term follow-up.
    Peselow ED; Tobia G; Karamians R; Pizano D; IsHak WW
    Psychiatry Res; 2015 Feb; 225(3):680-6. PubMed ID: 25496869
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.